Pacira BioSciences, Inc. — Institutional Ownership
Which tracked institutions hold PCRX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
25
Funds holding
$328415076
Total value held
Buying
18 added/new · 7 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $152218750 | 6735343 | -328937 | -4.66% |
| 2 | State Street Corp | $43383186 | 1919610 | +36243 | +1.92% |
| 3 | Goldman Sachs Group Inc | $35480101 | 1569916 | +269529 | +20.73% |
| 4 | Morgan Stanley | $31471623 | 1392548 | +199954 | +16.77% |
| 5 | Northern Trust Corp | $11738711 | 519412 | -9071 | -1.72% |
| 6 | Bank Of New York Mellon Corp | $6839406 | 302629 | -26987 | -8.19% |
| 7 | Principal Financial Group Inc | $6402218 | 283284 | +21896 | +8.38% |
| 8 | Barclays Plc | $6375640 | 282108 | — | NEW BUY |
| 9 | Invesco Ltd. | $6332293 | 244679 | -272745 | -52.71% |
| 10 | Blackrock, Inc. | $4262160 | 4425000 | +775000 | +21.23% |
| 11 | Bank Of America Corp /De/ | $4258676 | 188437 | +3630 | +1.96% |
| 12 | Royal Bank Of Canada | $4187000 | 185258 | — | NEW BUY |
| 13 | Prudential Financial Inc | $4132930 | 182873 | +22400 | +13.96% |
| 14 | Ameriprise Financial Inc | $3774335 | 167006 | -16590 | -9.04% |
| 15 | Citigroup Inc | $2030335 | 2024000 | +1000000 | +97.66% |
| 16 | Wells Fargo & Company/Mn | $1358338 | 52486 | +15306 | +41.17% |
| 17 | Raymond James Financial Inc | $1190501 | 52677 | +35121 | +200.05% |
| 18 | Citigroup Inc | $904299 | 34942 | +4147 | +13.47% |
| 19 | Franklin Resources Inc | $744037 | 32922 | -938 | -2.77% |
| 20 | Janus Henderson Group Plc | $526776 | 23319 | — | NEW BUY |
| 21 | Sei Investments Co | $480555 | 21261 | — | NEW BUY |
| 22 | Fifth Third Bancorp | $217350 | 9617 | +8810 | +1091.70% |
| 23 | Pnc Financial Services Group, Inc. | $84772 | 3751 | +492 | +15.10% |
| 24 | Us Bancorp \De\ | $19413 | 859 | -217 | -20.17% |
| 25 | Amalgamated Financial Corp. | $1671 | 21890 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.